tetracycline
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
17338
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
August 29, 2026
Helicobacter heilmannii Gastritis Identified on Random Gastric Biopsy in a Patient With Nondysplastic Barrett's Esophagus
(ACG 2026)
- "He was treated with 14 days of bismuth-based quadruple therapy using pantoprazole, metronidazole, tetracycline, and bismuth subsalicylate. Random gastric biopsies should be considered when symptoms persist, even when the gastric mucosa appears normal. Figure: Endoscopic images showing an irregular Z-line with otherwise grossly normal gastric and duodenal mucosa."
Biopsy • Clinical • Barrett Esophagus • Celiac Disease • Extranodal Marginal Zone Lymphoma • Gastric Cancer • Gastroenterology • Gastrointestinal Disorder • Hematological Malignancies • Immunology • Infectious Disease • Lymphoma • Marginal Zone Lymphoma • Peptic Ulcer • Solid Tumor
August 29, 2026
When Cannabis Hyperemesis Is Not the Whole Story: Refractory Multidrug-Resistant Helicobacter pylori Masquerading as Cannabis Hyperemesis Syndrome
(ACG 2026)
- "Gastric culture with susceptibility testing demonstrated resistance to amoxicillin, clarithromycin, metronidazole, levofloxacin, and rifampin, with susceptibility only to tetracycline. In patients with presumed CHS and recurrent or refractory symptoms, clinicians should maintain a broad differential and pursue endoscopic evaluation when appropriate. Early susceptibility-guided therapy is essential after multiple eradication failures to avoid delayed diagnosis and repeated ineffective treatment."
Gastrointestinal Disorder • Genetic Disorders • Infectious Disease • Obesity
August 29, 2026
The Other Helicobacter : Gastritis Caused by Helicobacter heilmannii
(ACG 2026)
- "Quadruple therapy of proton pump inhibitor, bismuth subsalicylate, tetracycline, and metronidazole was prescribed...Increased awareness among clinicians and pathologists is important to avoid misclassification and ensure appropriate treatment. Figure: Histology Identification of Helicobacter heilmannii in Gastric Biopsy"
Extranodal Marginal Zone Lymphoma • Gastroenterology • Gastrointestinal Disorder • Hematological Malignancies • Infectious Disease • Lymphoma • Marginal Zone Lymphoma
August 29, 2026
Simplified Vonoprazan Rescue Regimens for Persistent/Refractory Helicobacter pylori : A Rescue-Specific Meta-Analysis of Randomized Trials
(ACG 2026)
- "Additional prespecified comparisons were supported by only one eligible RCT each and were summarized without pooling: vonoprazan-amoxicillin had fewer adverse reactions than susceptibility-guided therapy (RR 0.29, 95% CI 0.16-0.54), adding Saccharomyces boulardii improved ITT eradication versus vonoprazan-amoxicillin alone (RR 1.16, 95% CI 1.03-1.30), and rifabutin-based vonoprazan triple therapy achieved comparable ITT eradication to quadruple therapy (RR 0.99, 95% CI 0.91-1.08). Six rescue-relevant RCTs were eligible; 3 RCTs (n=1,278) formed the main meta-analysis (vonoprazan-amoxicillin in 2 trials; vonoprazan-tetracycline in 1 trial). Dual therapy did not show a clear intention-to-treat (ITT) eradication advantage versus quadruple therapy (RR 0.94, 95% CI 0.85-1.05; I²=74.3%). Modified ITT (RR 0.93, 95% CI 0.84-1.04; I²=82.2%) and per-protocol analyses (RR 0.93, 95% CI 0.85-1.02; I²=76.3%) were concordant."
Retrospective data • Infectious Disease
August 29, 2026
Scleroderma, Stasis, and Sarcina: A Rare Gastric Infection in Systemic Sclerosis
(ACG 2026)
- "Case Description/ A 70-year-old woman with systemic sclerosis complicated by esophageal aperistalsis, and chronic use of methadone and trazodone presented with progressive dysphagia and reflux...She was treated with amoxicillin-clavulanate, high-dose proton pump inhibitor, and prucalopride as a prokinetic agent...Although ciprofloxacin plus metronidazole is the most commonly reported regimen, no formal treatment guidelines exist. In vitro susceptibility data suggest efficacy of penicillins, fluoroquinolones, macrolides, and tetracyclines. Our use of amoxicillin-clavulanate to avoid QT prolongation risk represents a novel therapeutic approach. This case highlights the importance of evaluating for underlying causes of delayed gastric emptying when S. ventriculi is detected, the variable clinical spectrum of this organism, and the role of individualized antibiotic selection when standard regimens are contraindicated."
Gastrointestinal Disorder • Immunology • Infectious Disease • Respiratory Diseases • Scleroderma • Systemic Sclerosis
August 29, 2026
Rifabutin Induced Febrile Neutropenia in Salvage Therapy for Refractory H. pylori Infection
(ACG 2026)
- "Case Description/ A 32âyearâold woman with recurrent dyspepsia, reflux, and bloating was found to have persistent H. pylori infection despite multiple eradication attempts, including clarithromycinâbased triple therapy, metronidazoleâbased therapy, and tetracyclineâ and levofloxacinâcontaining regimens...She was started on salvage therapy with rifabutin, doxycycline, bismuth, and pantoprazole...This case highlights the importance of baseline and interval CBC monitoring when prescribing rifabutinâcontaining salvage regimens for refractory H. pylori. Early recognition and prompt discontinuation typically result in rapid hematologic recovery."
Dyspepsia • Febrile Neutropenia • Hematological Disorders • Infectious Disease • Leukopenia • Neutropenia
August 29, 2026
Vonoprazan-Based Rescue Regimens Versus Bismuth Quadruple Therapy for Refractory Helicobacter pylori Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
(ACG 2026)
- "Three randomized controlled trials comprising 1,278 patients were included. Vonoprazan-based rescue regimens included vonoprazan-amoxicillin dual therapy, vonoprazan-tetracycline dual therapy, and vonoprazan-rifabutin-amoxicillin triple therapy, while comparator arms received BQT rescue regimens. For the primary outcome of ITT eradication, vonoprazan-based therapy demonstrated efficacy comparable to BQT (OR 0.94, 95% CI 0.71-1.25; p=0.662)."
Retrospective data • Review • Infectious Disease
August 29, 2026
First Reported Human Case of Helicobacter Felistomachi Gastritis Refractory to Standard and Salvage Eradication Therapy
(ACG 2026)
- "Completion of bismuth quadruple therapy with tetracycline was complicated by Clostridioides difficile colitis and treated with vancomycin...After a course of salvage rifabutin triple therapy, repeat biopsies revealed persistent chronic active non-pylori Helicobacter gastritis, and confirmatory sequencing identified Helicobacter felistomachi...Throughout this course, his concurrent uncontrolled ulcerative colitis required a prednisone taper and vedolizumab induction...Figure: Figure 2: IHC 100x Helicobacter immunohistochemical stain (100x) highlighting the elongated spiral morphology of Helicobacter felistomachi organisms within gastric glands. Species identification confirmed by 16S rRNA polymerase chain reaction sequencing."
Clinical • Dyspepsia • Extranodal Marginal Zone Lymphoma • Gastroenterology • Gastrointestinal Disorder • Hematological Malignancies • Immunology • Infectious Disease • Inflammatory Bowel Disease • Lymphoma • Marginal Zone Lymphoma • Peptic Ulcer • Ulcerative Colitis
August 29, 2026
Vonoprazan-Based Dual Therapy as a Rescue Regimen for Treatment-Experienced Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
(ACG 2026)
- "Four studies used vonoprazan-amoxicillin; one used vonoprazan-tetracycline, sensitivity analysis was applied for this study across all outcomes and did not materially affect the results. Our search yielded 180 citations; 29 were reviewed in full text. Five studies (4 RCTs, 1 retrospective) met inclusion criteria, comprising 1,990 patients (vonoprazan dual = 866 vs. comparator = 893)."
Retrospective data • Review • Infectious Disease
September 23, 2026
Hidradenitis Suppurativa from Preconception to Lactation: Clinical Treatment Decision-Making Review.
(PubMed, Dermatol Ther (Heidelb))
- "Topical clindamycin, benzoyl peroxide, chlorhexidine, and selected beta-lactam antibiotics appear to represent preferred options for mild disease or acute flares, whereas tetracyclines, retinoids, spironolactone, apremilast, Janus kinase inhibitors, and most glucagon-like peptide-1 (GLP-1) receptor agonists require avoidance or discontinuation because of fetal or neonatal safety concerns. Among biologics, tumor necrosis factor-α inhibitors remain the best-characterized agents, with certolizumab pegol offering minimal placental transfer and adalimumab or infliximab requiring individualized decisions regarding continuation and timing of discontinuation. Evidence for newer agents, including secukinumab and bimekizumab, is evolving but remains more limited. The review also highlights the importance of preconception counseling, medication transition, multidisciplinary delivery planning, postpartum flare prevention, breastfeeding-compatible therapy, and individualized..."
Journal • Review • Dermatology • Hidradenitis Suppurativa • Immunology • Oncology • Women's Health
September 25, 2026
Animal type outweighs growth stage in shaping the active antibiotic resistome in livestock manure.
(PubMed, Front Microbiol)
- "Metagenomic analysis identified 944 ARG subtypes, predominantly associated with tetracycline, multidrug, and macrolide-lincosamide-streptogramin (MLS) resistance...Overall, animal type was the dominant measured correlate of resistome composition, whereas growth stage was associated mainly with variation in selected ARG abundances. These observational findings require validation in multi-farm longitudinal studies before management or environmental-risk conclusions are drawn."
Journal
September 25, 2026
Slaughtered pigs as reservoirs of One Health-relevant antimicrobial resistance genes in Klebsiella pneumoniae from Brazil.
(PubMed, Front Microbiol)
- "Antimicrobial susceptibility was determined by disk diffusion and broth microdilution for colistin...High frequencies of non-susceptibility were observed for tetracycline (86.8%), ciprofloxacin (77.4%), and amoxicillin-clavulanate (67.9%), while 34 isolates (64.2%) were classified as MDR...These findings demonstrate a high occurrence of MDR K. pneumoniae carrying clinically important resistance determinants in pigs at slaughter and reveal the circulation of distinct genomic lineages harboring acquired virulence-associated loci. The results suggest that swine production systems may contribute to the maintenance and potential dissemination of One Health-relevant K. pneumoniae and highlight the importance of integrated genomic surveillance to support antimicrobial stewardship and food safety."
Journal • Infectious Disease • Pneumonia
September 25, 2026
Effects of PVA/TiO2 Composite Hydrogel-Modified PES Ultrafiltration Membranes on Antibiotic Removal Performance and Membrane Fouling Behavior.
(PubMed, Membranes (Basel))
- "Low pH favored sulfamethoxazole, tetracycline, and ofloxacin removal, while 5 μm particles increased sulfamethoxazole and tetracycline removal by 27.0% and 22.0%, respectively. Hermia model fitting suggested predominantly standard blocking-type hydraulic behavior under the tested pH conditions and complete blocking-type behavior in the presence of HA or particles. These results show that PVA/TiO2 modification improves PES membrane hydrophilicity and antibiotic removal, although fouling under complex conditions remains important."
Journal
September 25, 2026
Antibiotics modulate activity of mouse and human dorsal root ganglia neurons.
(PubMed, bioRxiv)
- "We found that β-lactams, macrolides, and tetracyclines induce calcium flux in sensory neurons within minutes of application...Pharmacological manipulations further revealed that cephalexin responses depend on TRPA1 activity whereas doxycycline responses require mitochondrial reactive oxygen species (ROS) production. These findings demonstrate that clinically relevant concentrations of antibiotics directly modulate sensory neuron activity through divergent mechanisms, thus expanding our current understanding of antibiotic side effects. Clinically relevant antibiotics induce calcium flux in mouse and human sensory neurons through unique, drug-specific mechanisms."
Journal • Preclinical • TRPA1
September 25, 2026
Oncohistone inhibition reshapes tumor-microenvironment communication in Diffuse Midline Glioma (DMG).
(PubMed, bioRxiv)
- "We generated a tetracycline-inducible PiggyBac-based oncohistone expression cassette in patient- and murine-derived models and validated inducible and reversible H3K27M expression...Importantly, inhibition of H3K27M disrupted these tumor-associated signaling networks and partially restored neuron- immune communication within the tumor microenvironment. Together, these findings demonstrate that H3K27M extensively reshapes the tumor microenvironment in these Diffuse Midline Gliomas and provides strong rationale for directly targeting the oncohistone as a therapeutic strategy for patients with H3K27M-mutant DMG."
Biomarker • Journal • Brain Cancer • Diffuse Midline Glioma • Glioma • Oncology • Pediatrics • Solid Tumor • SLC1A3
September 25, 2026
Phylogenomic Diversity, Serotype Heterogeneity and In Vivo Virulence of Flavobacterium psychrophilum Isolates From Rainbow Trout Farms in Türkiye.
(PubMed, J Fish Dis)
- "Antimicrobial susceptibility testing showed a high proportion of non-wild-type phenotypes for oxytetracycline, florfenicol and enrofloxacin; however, no acquired antimicrobial resistance genes were detected by genome-based screening. Collectively, these findings demonstrate that Turkish F. psychrophilum populations are phylogenomically diverse but retain largely conserved virulence-associated loci and immunoreactive antigenic structures. This study provides the first evidence of the CC-ST90/ST108 lineage in Türkiye and highlights the value of integrating genomic, serological, phenotypic, antigenic and experimental infection data for understanding the population structure, serotype heterogeneity and pathogenic potential of F. psychrophilum in rainbow trout aquaculture."
Heterogeneity • Journal • Preclinical • Infectious Disease
September 25, 2026
Longitudinal patterns of antimicrobial use across production stages in semi-intensive broiler systems in Uganda.
(PubMed, Prev Vet Med)
- "Tetracyclines accounted for 43.8% of total quantified AAI mass...Biomass-normalised AMU was not associated with reported clinical signs or deaths, suggesting that AMU patterns were not explained by reported disease occurrence alone. These findings identify early production stages, frequent use of combination products and antimicrobials of particular importance to human medicine, and high-use flocks as priorities for targeted stewardship, alongside strengthened preventive flock health management."
Journal
September 25, 2026
High prevalence and multidrug resistance of Methicillin-resistant Staphylococcus aureus at a provincial referral hospital in Zambia: A 5-year retrospective study.
(PubMed, PLOS Glob Public Health)
- "In resource-limited settings such as Zambia, staphylococcal infections are treated empirically with clindamycin or co-trimoxazole due to limited susceptibility testing...MRSA demonstrated significantly lower susceptibility than MSSA to non-beta-lactam antibiotics: clindamycin (46.2% vs. 67.7%), erythromycin (50.0% vs. 79.5%), ciprofloxacin (58.2% vs. 91.4%), and tetracycline (58.3% vs. 81.9%)...Empirical use of clindamycin and erythromycin for suspected staphylococcal skin and soft tissue infections should be reconsidered and guided by local antimicrobial susceptibility whenever available. Continued local surveillance and multicenter studies are needed to inform empirical treatment guidelines across Zambia."
Journal • Retrospective data • Infectious Disease • CAT
September 25, 2026
Non-destructive monitoring of antibiotic action in Bacillus subtilis biofilms using dual-parameter swept-source optical coherence tomography.
(PubMed, Biofouling)
- "Viable counts decrease by ∼2.5 log10 CFU/mL in both treated arms (p < 0.001), confirming substantial killing; γ nonetheless declined nonlinearly with respect to viability and continued falling after CFU/mL stabilized, indicating that γ reflects progressive physical quiescence rather than viable cell numbers. SSOCT attenuation and biospeckle thus offer a non-destructive complement to conventional viability assays."
Journal
September 24, 2026
Occurrence of Stenotrophomonas carrying β-lactamase-encoding genes in a veterinary hospital environment.
(PubMed, Vet Res Commun)
- "Antimicrobial susceptibility testing revealed a high resistance profile to ciprofloxacin, whereas resistance to tetracyclines, chloramphenicol, levofloxacin, and trimethoprim/sulfamethoxazole was less frequent. In accordance with the reported intrinsic resistance of Stenotrophomonas to a range of antibiotic classes, the strains were resistant to meropenem, ampicillin, cefoxitin, and amoxicillin/clavulanate...Together, these findings indicate that environmental Stenotrophomonas spp. strains from veterinary settings harbor multidrug resistance determinants, efflux-mediated mechanisms, and biofilm-forming capacity, highlighting their potential role in the maintenance and dissemination of clinically relevant antimicrobial resistance."
Journal
September 24, 2026
Gentiana sino-ornata Balf. f. ethyl acetate extract alleviates high-fat diet- and tetracycline-induced liver injury in mice: insights from serum pharmacochemistry, network pharmacology, and experimental validation.
(PubMed, Front Pharmacol)
- "In vivo experiments showed that GSEA markedly alleviated HFD- and tetracycline-induced liver injury by suppressing the expression of inflammation- and glucolipid-metabolism-related genes, attenuating hepatic inflammation, modulating the gut microbiota, and partially regulating the PI3K/Akt/FoxO1 signaling pathway. Collectively, these findings provide mechanistic evidence supporting the potential application of GSEA as a natural therapeutic agent for the prevention or treatment of liver injury associated with metabolic dysfunction and tetracycline exposure."
Journal • Preclinical • Hepatology • Inflammation • Liver Failure • Metabolic Disorders • Metabolic Dysfunction-Associated Steatotic Liver Disease • AKT1
September 24, 2026
Antimicrobial resistance characteristics of enterococcus and analysis of intra-farm transmission associations in large-scale laying hen production.
(PubMed, Poult Sci)
- "The predominant resistance phenotypes were to macrolides, tetracyclines, and sulfonamides...Resistance phenotypes for enrofloxacin and sulfisoxazole were strongly associated with environmental samples, highlighting the farm environment as a critical potential control point for AMR risk mitigation. Leveraging whole-genome sequencing, this study explores the transmission risk of antimicrobial-resistant Enterococcus in layer production and provides insights for preventing AMR risks originating from layer farms."
Journal
September 24, 2026
Microbiological safety and antimicrobial resistance in cashew-based plant-based cheese analogues.
(PubMed, Braz J Microbiol)
- "Resistance was detected in a limited number of isolates, mainly to ciprofloxacin, tetracycline, and gentamicin, whereas C. malonaticus exhibited resistance to penicillin. A total of eight antimicrobial resistance genes were identified, four of which were located on plasmids in C. malonaticus and L. brevis. These findings suggest that microorganisms associated with plant-based cheese analogues may act as reservoirs of antimicrobial resistance determinants, highlighting the importance of safety assessment and microbiological surveillance of strains intended for technological or probiotic applications."
Journal
September 18, 2026
Bacillus Probiotics With Bismuth Quadruple Therapy for Helicobacter Pylori Infection
(clinicaltrials.gov)
- P=N/A | N=336 | Not yet recruiting | Sponsor: Anabio R&D
New trial • Infectious Disease
September 23, 2026
Type II Minocycline-Induced Hyperpigmentation During Long-Term Management of an Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Acneiform Eruption.
(PubMed, Cureus)
- "We report the case of a 40-year-old man with hereditary leiomyomatosis and renal cell carcinoma (HLRCC) who developed an EGFR inhibitor-associated papulopustular eruption shortly after initiating erlotinib and bevacizumab. Persistent disease despite doxycycline therapy and concern for doxycycline-associated photosensitivity prompted a transition to long-term minocycline...This case highlights the importance of longitudinal dermatologic follow-up in patients receiving prolonged tetracycline therapy for EGFR inhibitor-associated cutaneous toxicities. Periodic reassessment of treatment necessity, dose optimization, and early recognition of delayed medication-related adverse effects may minimize cumulative toxicity while preserving effective oncologic therapy."
Journal • Dermatology • Genito-urinary Cancer • Nephrology • Oncology • Renal Cell Carcinoma • Solid Tumor
1 to 25
Of
17338
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694